Log In
Print this Print this

tiapamil (ORE5002)

  Manage Alerts
Collapse Summary General Information
Company Ore Holdings Inc.
DescriptionL-type calcium channel antagonist
Molecular Target Calcium channel
Mechanism of ActionCalcium channel blocker
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationCognitive dysfunction
Indication DetailsTreat cognitive disorder
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today